Skip to main content

Kaye Mark

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Kaye Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ELV Elevance Health, Inc.

EVP & CFO1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 25, 2025 (view filing)Apr 241 dayKaye MarkEVP & CFOSSale−4.59K$424.82−$1.95M−19.5%19.0K after

MCO Moodys Corp

EVP & Chief Financial Officer6 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 8, 2023 (view filing)Aug 71 dayKaye MarkEVP & Chief Financial OfficerSSale−15.2K$340.97−$5.17M−77.3%4.45K after6 lots
May 22, 2023 (view filing)May 193 daysKaye MarkEVP & Chief Financial OfficerSSale−975$317.91−$310.0K−10.5%8.32K after
Aug 16, 2022 (view filing)Aug 151 dayKaye MarkEVP & Chief Financial OfficerSSale−3.11K$322.25−$1.00M−36.8%5.34K after2 lots
Mar 3, 2022 (view filing)Mar 21 dayKaye MarkEVP & Chief Financial OfficerSSale−3.70K$325.24−$1.20M−40.7%5.38K after
Nov 19, 2021 (view filing)Nov 181 dayKaye MarkEVP & Chief Financial OfficerSSale−316$398.28−$125.9K−6.4%4.58K after
Aug 17, 2021 (view filing)Aug 161 dayKaye MarkEVP & Chief Financial OfficerSSale−3.13K$379.69−$1.19M−39.0%4.90K after3 lots